MassMutual Private Wealth & Trust FSB Purchases 8,218 Shares of Danaher Corporation $DHR

Key Points

• MassMutual Private Wealth & Trust FSB increased its stake in Danaher Corporation by 7.5% during the 2nd quarter, now holding 117,426 shares worth approximately $23.2 million.
• Analysts remain positive on Danaher, with a consensus rating of "Moderate Buy" and an average price target of $246.35, while several firms have recently adjusted their price targets.
• Danaher reported quarterly earnings of $1.80 per share, exceeding expectations, while also declaring a quarterly dividend of $0.32 to be paid on October 31st.

MassMutual Private Wealth & Trust FSB boosted its position in Danaher Corporation (NYSE:DHR - Free Report) by 7.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 117,426 shares of the conglomerate's stock after acquiring an additional 8,218 shares during the period. MassMutual Private Wealth & Trust FSB's holdings in Danaher were worth $23,196,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Hills Bank & Trust Co raised its holdings in shares of Danaher by 0.3% during the 1st quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate's stock worth $3,693,000 after buying an additional 53 shares in the last quarter. Sageworth Trust Co increased its holdings in Danaher by 2.3% in the 1st quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate's stock worth $493,000 after purchasing an additional 54 shares in the last quarter. 1834 Investment Advisors Co. increased its holdings in Danaher by 3.3% in the 1st quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate's stock worth $342,000 after purchasing an additional 54 shares in the last quarter. Rakuten Securities Inc. increased its holdings in Danaher by 33.3% in the 1st quarter. Rakuten Securities Inc. now owns 224 shares of the conglomerate's stock worth $46,000 after purchasing an additional 56 shares in the last quarter. Finally, Kingswood Wealth Advisors LLC increased its holdings in Danaher by 1.6% in the 1st quarter. Kingswood Wealth Advisors LLC now owns 3,466 shares of the conglomerate's stock worth $710,000 after purchasing an additional 56 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Guggenheim reissued a "buy" rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Evercore ISI decreased their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Robert W. Baird raised their target price on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research note on Friday, July 18th. Finally, Wells Fargo & Company decreased their target price on Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 23rd. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $246.35.

Insider Transactions at Danaher

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.20% of the company's stock.

Danaher Price Performance

Shares of NYSE DHR opened at $188.24 on Tuesday. The stock has a market cap of $134.79 billion, a PE ratio of 40.05, a price-to-earnings-growth ratio of 2.65 and a beta of 0.75. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The stock has a fifty day moving average of $200.98 and a 200-day moving average of $198.64.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. Danaher's payout ratio is 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.